SCHEMBL358839

SCHEMBL358839

CC(C)C(=O)O[C@H](C)OC(=O)Nc1cc[c]cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.38
ALOX15 P16050 1/20 0.37
MAPT P10636 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
TP53 P04637 1/20 0.33
GAA P10253 1/20 0.33
KLK7 P49862 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL363979 0.85 HPGD (0.41) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL2358907 0.82 SMN1; SMN2 (0.62) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL358841 0.78 NPC1 (0.48) HPGDSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL348939 0.75 FFAR1 (0.43) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL351084 0.75 FFAR1 (0.43) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL350646 0.75 SMN1; SMN2 (0.42) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL1196294 0.74 SMN1; SMN2 (0.61) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL351083 0.74 CRHBP (0.47) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL348938 0.74 CRHBP (0.47) HPGDSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL1148135 0.72 ALDH1A1 (0.56) HPGDSMN1; SMN2NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009646-A1 METHODS OF TREATING FRAGILE X SYNDROME, DOWN'S SYNDROME, AUTISM AND RELATED DISORDERS XENOPORT, INC. (US) 2012-01-19 WO disclosed